jump to content jump to footer
Participants at the RECIST and Beyond workshop in Cologne during hands-on training with mint Lesion for structured tumor response assessment.
The two-day “RECIST and Beyond” workshop at radCIO Cologne offered intensive hands-on training on RECIST, iRECIST, mRECIST and LI-RADS, with real-case reporting performed directly in mint Lesion.

Successful “RECIST and Beyond” Workshop in Cologne: Advancing Precision in Oncologic Imaging

How can complex tumor findings be assessed accurately, reproducibly, and in line with clinical guidelines?

This central question shaped this year’s “RECIST and Beyond” workshop at the Radiological Center for Integrated Oncology (radCIO) at University Hospital Cologne. Over two intensive days in late September 2025, participants received exactly the practical, hands-on insights needed for their daily clinical routine.

Radiologists, oncologists, and specialists from related fields worked in an interactive hands-on format, performing their assessments directly in mint Lesion. This allowed them to immediately apply what they learned – structured, standardized, and fully traceable.

Day 1: Response Monitoring in Modern Oncology

The program focused on RECIST 1.1, iRECIST, mRECIST, LI-RADS Treatment Response, and the Lugano Classification. Participants learned how to reliably evaluate tumor response and progression, and how standardized reporting workflows enhance consistency and clarity in clinical decision-making.

Day 2: Liver and Biliary Tract Diagnostics with a Focus on LI-RADS

Saturday was dedicated to the classification, interpretation, and treatment response assessment of HCC as well as other hepatic and biliary tumors – highlighting the correct application of LI-RADS.

Learning in a Personalized Setting

With a deliberately limited number of participants, the workshop created an ideal environment for exchange, discussion, and individual feedback.

Prof. Dr. Thorsten Persigehl, scientific dorector of the event, summarized it perfectly:

“Through the independent hands-on training at the laptops, every participant will take something valuable back into their clinical routine reporting.”

We are delighted that we were able to support this workshop with mint Lesion, enabling participants to experience firsthand how structured reporting and decision support can increase confidence in everyday oncologic imaging.

More workshops are already in planning.
Follow us on LinkedIn to stay informed.

From PCWG3 to PCWG4: Evolving Standards in Prostate Cancer Clinical Trials

The Prostate Cancer Working Group 4 (PCWG4) updates and extends the recommendations of PCWG3 to reflect a patient-centric approach, the emergence of…

Read more
Mint Medical and mediaire strengthen the prostate cancer care pathway with AI-Powered MRI Solutions

Mint Medical, a Snke company, and mediaire announce a collaboration to advance AI‑powered MRI workflows through the interoperability of mint Lesion…

Read more
Screenshot of the mint Lesion interface showing RANO 2.0 configuration, tumor burden calculations, and structured neuro-oncology assessment tools.
mint Lesion fully supports RANO 2.0 implementation with configurable parameters, automated tumor burden calculations, and structured workflows for neuro-oncology clinical trials.
Implementing RANO 2.0 for Neuro-Oncology Clinical Trials in mint Lesion

Tumor response assessment in neuro-oncology clinical trials requires careful attention to measurement protocols and confirmation scan requirements. To…

Read more
scroll-top